The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15711
StudyName: Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT02366143
Date of export from the portal: 02.07.2020
Date of Upload / last change: 09.06.2016
License: Creative Commons BY 4.0

----

Description: 
A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [IMpower 150]; ODM derived from: https://clinicaltrials.gov/show/NCT02366143
